Simplified Summary
Khavinson bioregulators are ultra-short peptides (di-, tri-, and tetrapeptides) derived from tissue extracts and synthesised for use in preclinical research. The principal mechanistic hypothesis studied in preclinical settings is that these short peptides can penetrate cell nuclei and interact with complementary DNA sequences at gene promoter regions, potentially influencing gene transcription for tissue-specific proteins. This gene-regulatory mechanism has been examined in cell culture and animal model studies for a range of short peptides targeting different tissue types.
Among the best-studied Khavinson peptides in preclinical settings are tissue-specific peptides including Epithalon (epitalon), a tetrapeptide studied for telomere biology and pineal gland function; Thymalin and Thymulin, studied for thymic and immune cell biology; Cortagen, studied for cardiac and vascular biology; and Vilon, studied for immune modulation. Multiple additional short peptides targeting specific tissues including liver, cartilage, ovary, prostate, lung, and vascular tissue have been characterised in preclinical studies.
Preclinical research on Khavinson bioregulators has been conducted primarily in Soviet and Russian research institutions over several decades. Studies have examined peptide effects on longevity markers, immune function, organ-specific gene expression, and age-related biological changes in animal models. These studies have employed a range of biochemical, histological, and functional endpoints to characterise biological activity.
Tissue-Specific Bioregulators and Their Preclinical Research Focus
- Chonluten (Glu-Asp-Leu) — Lung-targeted peptide studied in preclinical respiratory biology models for its effects on bronchial epithelial cell biology and lung tissue function.
- Cortagen (Ala-Glu-Asp-Pro) — Cardiac-targeted tetrapeptide studied for its effects on cardiac cell biology and potential cardioprotective properties in preclinical heart tissue research.
- Crystagen (Gly-Leu-Tyr) — Studied for immune system biology, particularly in the context of lymphocyte function and immune cell gene expression in preclinical model systems.
- Livagen (Lys-Glu-Asp-Ala) — Liver-targeted peptide studied in preclinical hepatic biology models, including liver cell function and response to injury in relevant laboratory systems.
- Ovagen (Glu-Asp-Leu) — Ovary and liver-targeted peptide studied in preclinical female reproductive biology and hepatic function research.
- Pancragen (Lys-Glu-Asp-Trp) — Pancreas-targeted tetrapeptide studied in preclinical pancreatic cell biology research, including beta cell function investigations.
- Prostamax (Lys-Glu-Asp) — Prostate-targeted peptide studied in preclinical prostate tissue biology research examining cellular proliferation and function markers.
- Thymogen (Glu-Trp) — Thymus-targeted dipeptide studied in preclinical immune system research for its effects on T-lymphocyte biology and immune function parameters.
- Vesilute (Lys-Glu-Asp-Pro) — Urinary tract-targeted peptide studied in preclinical urothelial biology and bladder tissue research.
- Vesugen (Lys-Glu-Asp) — Vascular-targeted peptide studied in preclinical vascular endothelial biology and blood vessel function research.
Key Research Approaches and Findings
Preclinical research on Khavinson peptides has examined several putative mechanisms of action. The chromatin-binding hypothesis proposes that short peptides interact directly with double-stranded DNA at specific regulatory sequences, and has been examined through in vitro DNA-binding assays and chromatin immunoprecipitation approaches in cell-based systems. Preclinical gene expression studies have used microarray and PCR-based methods to characterise changes in tissue-specific gene expression profiles following peptide treatment in cell culture and animal model systems.
Longevity and ageing-related research has been a particular focus of Khavinson bioregulator studies, with preclinical investigations examining whether these peptides influence biomarkers of cellular ageing, including telomere length, antioxidant enzyme activity, and apoptosis markers in various tissue and animal model systems. Epithalon, the pineal gland tetrapeptide, has been most extensively studied for ageing-related endpoints, with animal model studies examining lifespan effects in rodent models.
Immune function research has examined multiple short peptides for their effects on lymphocyte subpopulations, cytokine production, and immune cell activation markers in animal models. These studies have been conducted primarily in the context of ageing-associated immune decline research, examining whether peptide bioregulators influence markers of immunosenescence in older animal cohorts.
Research Applications
- Gene regulatory biology research examining whether short peptides influence tissue-specific gene expression through putative DNA-binding mechanisms in cell-based systems.
- Ageing and longevity biology research using Khavinson peptides to examine biomarkers of cellular ageing and age-related functional decline in animal models.
- Tissue-specific organ biology research using individual peptides as research tools in relevant tissue cell culture and organ model systems.
- Immune function research examining effects of peptide bioregulators on lymphocyte biology and immune marker profiles in preclinical ageing model systems.
For research use only. Capital Peptides products are not approved by the TGA for therapeutic use. By purchasing you confirm you are a licensed research entity or qualified professional.